http://www.packaging-gateway.com/features/feature56362/
12-Jun-2009 – New European legislation could present makers of beauty foods, beverages and supplements with regulatory headaches unless they are careful with their claims.
LONDON — GlaxoSmithKline PLC said Monday it had reached a deal with Indian drug developer Dr. Reddy’s Laboratories Ltd. to develop and market selected products across many emerging markets.
London-based Glaxo did not reveal terms of the deal, which is effective immediately but excludes India.
Under the agreement, Glaxo will gain exclusive access to Dr. Reddy’s portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management.
http://www.pharmpro.com/ShowPR.aspx?PUBCODE=021&ACCT=0000100&ISSUE=0906&RELTYPE=IN&PRODCODE=0000&PRODLETT=DH&CommonCount=0
A leading French pharmaceutical company aims to establish a local research and development partnership within the year that could benefit Korea’s health care and biotech industries, the government said yesterday.
The Ministry of Knowledge Economy said Sanofi-Aventis plans to select a local investment partner that best meets its R&D requirements by December.
http://joongangdaily.joins.com/article/view.asp?aid=2906173
12-Jun-2009 – The Local Government Association (LGA) has urged UK companies to contribute to the ₤100m annual disposal costs of excess packaging, in an effort to reduce package wastage.
Tuesday 29 and Wednesday 30 September 2009, Munich, Germany
http://www.pharmapackaging-events.com/
11-Jun-2009 – Companies making green claims should be prepared for a growing number of eco-fraud litigation cases, warns an article published in a legal journal.